According to the latest information from the Hong Kong Stock Exchange, on October 20, shareholders of BIOHEART-B (02185) transferred their shares from China Securities Depository and Clearing Hong Kong to Morgan Stanley Hong Kong Securities, with a transfer value of HKD 135 million, accounting for 6.68% of the total. On the same day, BIOHEART-B announced that it received a notification from its controlling shareholder, Wang Li. Based on his recognition of the company's value and confidence in its future overall business development and growth potential, Mr. Wang plans to acquire additional H shares of the company in the public market using his own funds through Winning Powerful Limited, a company registered in Hong Kong and fully owned by Mr. Wang, within approximately 12 months from the date of this announcement, with an expected total amount not exceeding HKD 15 million. As of the date of this announcement, Winning Powerful Limited directly owns 45.6456 million H shares of the company, representing about 18.75% of the total issued shares.